{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:17:56Z","timestamp":1740028676729,"version":"3.37.3"},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T00:00:00Z","timestamp":1269388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p><jats:bold>Aims:\u2002<\/jats:bold>Atypical antipsychotics are increasingly used in the management of acute mania. This study was conducted to investigate the efficacy and tolerability of zotepine compared to haloperidol in combination with a mood stabilizer (lithium or valproate) for treatment of acute mania.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>This was a multi\u2010center, randomized, rater\u2010blinded, parallel\u2010group, flexible\u2010dose study. Forty\u2010five hospitalized patients with moderate\u2010to\u2010severe manic, bipolar disorder (DSM\u2010IV) were randomly assigned to a zotepine or a haloperidol 4\u2010week treatment group.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>There was no significant between\u2010group difference in the Young Mania Rating Scale total scores between the zotepine and haloperidol groups (\u221223.7\u2003\u00b1\u200312.1 vs \u201322.3\u2003\u00b1\u200311.0, respectively). The adverse events in both groups were mild to moderate. The haloperidol group reported a higher incidence of treatment\u2010related adverse events, especially parkinsonism and akathisia, compared to the zotepine group. Serum uric acid decreased more in the zotepine group than in the haloperidol group.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold>In combination with a mood stabilizer, zotepine appears to be as effective as haloperidol in treating moderate\u2010to\u2010severe mania in the acute phase, but has the advantages of lowering hyperuricemia and fewer extrapyramidal side\u2010effects. Double\u2010blinded studies with larger sample sizes are warranted to confirm these findings.<\/jats:p>","DOI":"10.1111\/j.1440-1819.2010.02066.x","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T10:12:21Z","timestamp":1269425541000},"page":"162-169","source":"Crossref","is-referenced-by-count":13,"title":["A single\u2010blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate\u2010to\u2010severe mania"],"prefix":"10.1111","volume":"64","author":[{"given":"Hung\u2010Yu","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaw\u2010Hua","family":"Jou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong\u2010Yuh","family":"Juang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching\u2010Jui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahn\u2010Jyh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung\u2010Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan\u2010Ying","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.1.133"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0109"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199912000-00003"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890427583","volume-title":"Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association","author":"Kane JM","year":"1992"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800040052008"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.11.1455"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.414"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HEGH study group","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.229"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0401"},{"key":"e_1_2_5_14_2","first-page":"406","article-title":"Antimanic effect of zotepine","volume":"8","author":"Harada T","year":"1986","journal-title":"Clin. Ther."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2005.00241.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"e_1_2_5_18_2","first-page":"97","article-title":"The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling","volume":"24","author":"Overall JE","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"e_1_2_5_19_2","first-page":"218","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy W","year":"1976"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_2_5_22_2","first-page":"534","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy W","year":"1976"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.2.141"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.1.62"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00115.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.101003218.x"},{"key":"e_1_2_5_28_2","first-page":"811","article-title":"Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: A double\u2010blind comparison with haloperidol","volume":"100","author":"Hwang TJ","year":"2001","journal-title":"J. Formos. Med. Assoc."},{"key":"e_1_2_5_29_2","first-page":"81","article-title":"A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: A parallel\u2010group double\u2010blind trial","volume":"32","author":"Petit M","year":"1996","journal-title":"Psychopharmacol. Bull."},{"key":"e_1_2_5_30_2","first-page":"69","article-title":"[Effects of zotepine, a psychotropic agent, on the serum uric acid level of inpatients at a psychiatric hospital]","volume":"2","author":"Yoshida H","year":"1982","journal-title":"Yakubutsu Seishin Kodo"}],"container-title":["Psychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1819.2010.02066.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1819.2010.02066.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:39:25Z","timestamp":1739986765000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1819.2010.02066.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,24]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1440-1819.2010.02066.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1819.2010.02066.x","archive":["Portico"],"relation":{},"ISSN":["1323-1316","1440-1819"],"issn-type":[{"type":"print","value":"1323-1316"},{"type":"electronic","value":"1440-1819"}],"subject":[],"published":{"date-parts":[[2010,3,24]]}}}